Clinical Trials in Georgia

Showing 2621-2640 of 19,050 trials

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

NCT06983041

The objective of this study is to determine clinical cure rate and safety of a proprietary Vaginal Cooling Device (VCD) in women with VCC. In addition, the safety, mycological cure rates, the speed and efficacy of symptom resolution, vaginal hyphae and polymorphonuclear (PMN) scores, and Quality-of-Life (QoL) parameters will be determined.

Vulvovaginal Candidiasis (VVC)Yeast Vaginitis

Coologics, Inc55 participantsStarted May 2025

Jacksonville, Florida, United States • Miami, Florida, United States • Smyrna, Georgia, United States +7 more locations

RECRUITINGPhase 1/265 miles

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

NCT06926920

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan-hziy (SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC). The primary objectives of this study are to assess the safety and tolerability of SG given at alternate dose and schedule, to assess the effect on objective response rate (ORR) and progression-free survival (PFS).

Triple Negative Breast Cancer

Gilead Sciences100 participantsStarted Apr 2025

Los Angeles, California, United States • Atlanta, Georgia, United States • Westwood, Kansas, United States +13 more locations

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Find Trials by Condition in Georgia

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Pivotal Study of the Velocity™ pAVF System

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

GDNF Gene Therapy for Multiple System Atrophy

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)